New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 23, 2014
07:09 EDTGSKGlaxoSmithKline reports Q2 core EPS down 12% to 19.1p
Reports Q2 turnover down 4% to GBP5.56B. GSK said Pharmaceutical and Vaccines sales were down 4% primarily due to continued increased competition in U.S. respiratory market and generic competition to Lovaza. It added, "With declining Advair sales, new sales growth expected from Breo, Anoro and Incruse, together with anticipated anticipated products. Expect to maintain respiratory leadership position well into next decade."
News For GSK From The Last 14 Days
Check below for free stories on GSK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 10, 2014
09:58 EDTGSKGlaxoSmithKline has a conference call hosted by JPMorgan
Subscribe for More Information
September 9, 2014
06:25 EDTGSKDocuments show DOJ probed GSK China unit in 2012, Reuters says
Internal documents revealed that a U.S. anti-bribery investigation into GlaxoSmithKline (GSK) touched on the firm's Chinese consumer healthcare division two years ago, which infers that the company's compliance issues in the country could be broader than initially discovered, according to Reuters, citing the documents. Reference Link
September 8, 2014
08:48 EDTGSKGilead announces AMBITION study results in collaboration with Glaxo
Subscribe for More Information
September 7, 2014
13:57 EDTGSKGlaxoSmithKline Ebola vaccine works in tests on monkeys, Bloomberg says
Subscribe for More Information
September 1, 2014
11:13 EDTGSKCipla introduces generic version of GSK's Advair in Europe, Reuters says
India's Cipla has launched a generic version of GlaxoSmithKline's anti-asthma inhaler Advair in Germany and Sweden, says Reuters. Reference Link
August 31, 2014
14:04 EDTGSKWorldwide Business Research to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use